Literature DB >> 3857622

mRNA precursor splicing in vivo: sequence requirements determined by deletion analysis of an intervening sequence.

V L van Santen, R A Spritz.   

Abstract

To define the extent of intervening sequence required for splicing higher eukaryotic mRNA precursors in vivo, we constructed deletions within the second intervening sequence of the human G gamma-globin gene that progressively approach the donor or acceptor splice sites. Most of the intervening sequence can be deleted with no effect on splicing. At the donor splice site, 6 bases of intervening sequence are sufficient for accurate and efficient splicing. At the acceptor splice site, 20 bases are sufficient for accurate and efficient splicing, and 16 bases are sufficient for accurate splicing but at a reduced level. However, 15 bases are insufficient for splicing at a significant level. The effect of deletions ending near the acceptor splice site is independent of whether an A-G dinucleotide is introduced into the acceptor splice site region by the deletion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857622      PMCID: PMC397671          DOI: 10.1073/pnas.82.9.2885

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Evidence for the biochemical role of an internal sequence in yeast nuclear mRNA introns: implications for U1 RNA and metazoan mRNA splicing.

Authors:  C W Pikielny; J L Teem; M Rosbash
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

2.  Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes.

Authors:  R Treisman; S H Orkin; T Maniatis
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

3.  Deletions at intervening sequence splice sites in the alcohol dehydrogenase gene of Drosophila.

Authors:  C Benyajati; A R Place; N Wang; E Pentz; W Sofer
Journal:  Nucleic Acids Res       Date:  1982-11-25       Impact factor: 16.971

4.  Unusual splice sites revealed by mutagenic inactivation of an authentic splice site of the rabbit beta-globin gene.

Authors:  B Wieringa; F Meyer; J Reiser; C Weissmann
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

5.  A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.

Authors:  R Treisman; N J Proudfoot; M Shander; T Maniatis
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

6.  Protein structural domains in the Caenorhabditis elegans unc-54 myosin heavy chain gene are not separated by introns.

Authors:  J Karn; S Brenner; L Barnett
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site.

Authors:  S E Antonarakis; S H Irkin; T C Cheng; A F Scott; J P Sexton; S P Trusko; S Charache; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Point mutations identify the conserved, intron-contained TACTAAC box as an essential splicing signal sequence in yeast.

Authors:  C J Langford; F J Klinz; C Donath; D Gallwitz
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

9.  Evidence for an intron-contained sequence required for the splicing of yeast RNA polymerase II transcripts.

Authors:  C J Langford; D Gallwitz
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

10.  RNA splice site selection: evidence for a 5' leads to 3' scanning model.

Authors:  K M Lang; R A Spritz
Journal:  Science       Date:  1983-06-24       Impact factor: 47.728

View more
  19 in total

1.  Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome.

Authors:  Lisa L Wang; Kim Worley; Anu Gannavarapu; Murali M Chintagumpala; Moise L Levy; Sharon E Plon
Journal:  Am J Hum Genet       Date:  2002-05-09       Impact factor: 11.025

2.  Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing.

Authors:  S L Berberich; C M Stoltzfus
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  In vivo splicing of the premRNAs from early region 3 of adenovirus-2: the products of cleavage at the 5' splice site of the common intron.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

4.  Coordinate loss of MHC class II expression in the diffuse large B cell lymphoma cell line OCI-Ly2 is due to a novel mutation in RFX-AP.

Authors:  Meghan Bushway; Kelly A Cycon; Kathleen Mulvaney; Shawn P Murphy
Journal:  Immunogenetics       Date:  2009-12-19       Impact factor: 2.846

5.  Molecular consequences of truncations of the first exon for in vitro splicing of yeast actin pre-mRNA.

Authors:  M Duchêne; A Löw; A Schweizer; H Domdey
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

6.  Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.

Authors:  M Polvino-Bodnar; D Shedd; G Miller
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Human adenovirus type 5 variants with sequence alterations flanking the E2A gene: effects on E2 expression and DNA replication.

Authors:  C Caravokyri; K N Leppard
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

8.  A novel H-2K splice form: predictions for other alternative H-2 splicing events.

Authors:  J M Vogel; R Y Morse; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

9.  Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

Authors:  Christopher R Logg; Brian T Baranick; Nathan A Lemp; Noriyuki Kasahara
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

10.  Short donor site sequences inserted within the intron of beta-globin pre-mRNA serve for splicing in vitro.

Authors:  A Mayeda; Y Ohshima
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.